These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38901207)

  • 1. Recent advances in biomimetic cell membrane-camouflaged nanoparticles for cancer therapy.
    Alimohammadvand S; Kaveh Zenjanab M; Mashinchian M; Shayegh J; Jahanban-Esfahlan R
    Biomed Pharmacother; 2024 Aug; 177():116951. PubMed ID: 38901207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics.
    Zhang M; Cheng S; Jin Y; Zhang N; Wang Y
    Clin Transl Med; 2021 Feb; 11(2):e292. PubMed ID: 33635002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cell delivery and cell membrane camouflaged PLGA nanoparticles in the delivery of shikonin for colorectal cancer treatment.
    Zhou J; Jiang Z; Sun R; Pan D; Du Q; Zhou X; Chen Y; Chen Y; Peng J
    Colloids Surf B Biointerfaces; 2024 Sep; 241():114017. PubMed ID: 38865869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Membrane-Camouflaged Silver Metal-Organic Framework Biomimetic Nanoparticles for the Treatment of Triple-Negative Breast Cancer.
    Liu H; Cai G; Yuan S; Zhou X; Gui R; Huang R
    Mol Pharm; 2024 Jul; 21(7):3577-3590. PubMed ID: 38857525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics.
    Vijayan V; Uthaman S; Park IK
    Polymers (Basel); 2018 Sep; 10(9):. PubMed ID: 30960908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
    Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
    Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minimalist cancer cell membrane-shielded biomimetic nanoparticle for nasopharyngeal carcinoma active-targeting therapy.
    Sun S; Han R; Sun Y; Chen W; Zhao L; Guan X; Zhang W
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113909. PubMed ID: 38599076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies.
    Ozsoy F; Mohammed M; Jan N; Lulek E; Ertas YN
    ACS Appl Bio Mater; 2024 May; 7(5):2637-2659. PubMed ID: 38687958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell membrane-camouflaged nanoparticles for drug delivery.
    Luk BT; Zhang L
    J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy.
    Kunde SS; Wairkar S
    Int J Pharm; 2021 Apr; 598():120395. PubMed ID: 33639226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
    Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
    J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment.
    Tao T; Rehman SU; Xu S; Zhang J; Xia H; Guo Z; Li Z; Ma K; Wang J
    J Mater Chem B; 2024 May; 12(17):4080-4096. PubMed ID: 38577851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy.
    Wu M; Le W; Mei T; Wang Y; Chen B; Liu Z; Xue C
    Int J Nanomedicine; 2019; 14():4431-4448. PubMed ID: 31354269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
    Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
    ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer.
    Rezaei S; de Araújo Júnior RF; da Silva ILG; Schomann T; Eich C; Cruz LJ
    Biomater Adv; 2023 Aug; 151():213456. PubMed ID: 37196459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomembrane camouflaged nanoparticles: A paradigm shifts in targeted drug delivery system.
    Qureshi SA; Rafiya K; Awasthi S; Jain A; Nadaf A; Hasan N; Kesharwani P; Ahmad FJ
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113893. PubMed ID: 38631282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Biomimetic Nanoparticles based on the Cell Membrane in Tumor Therapy.
    Gong Y; Huang J
    Curr Top Med Chem; 2023; 23(10):907-920. PubMed ID: 37102484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in biomimetic nanomaterial delivery systems: harnessing nature's inspiration for targeted drug delivery.
    Kang W; Xu Z; Lu H; Liu S; Li J; Ding C; Lu Y
    J Mater Chem B; 2024 Jul; 12(29):7001-7019. PubMed ID: 38919030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.